Mutations in the human AAA-ATPase VPS4 isoform, VPS4A, cause severe neurodevelopmental defects and congenital dyserythropoietic anemia (CDA). VPS4 is a crucial component of the endosomal sorting ...complex required for transport (ESCRT) system, which drives membrane remodeling in numerous cellular processes, including receptor degradation, cell division, and neural pruning. Notably, while most organisms encode for a single VPS4 gene, human cells have 2 VPS4 paralogs, namely VPS4A and VPS4B, but the functional differences between these paralogs is mostly unknown. Here, we set out to investigate the role of the human VPS4 paralogs in cytokinetic abscission using a series of knockout cell lines. We found that VPS4A and VPS4B hold both overlapping and distinct roles in abscission. VPS4A depletion resulted in a more severe abscission delay than VPS4B and was found to be involved in earlier stages of abscission. Moreover, VPS4A and a monomeric-locked VPS4A mutant bound the abscission checkpoint proteins CHMP4C and ANCHR, while VPS4B did not, indicating a regulatory role for the VPS4A isoform in abscission. Depletion of VTA1, a co-factor of VPS4, disrupted VPS4A-ANCHR interactions and accelerated abscission, suggesting that VTA1 is also involved in the abscission regulation. Our findings reveal a dual role for VPS4A in abscission, one that is canonical and can be compensated by VPS4B, and another that is regulatory and may be delivered by its monomeric form. These observations provide a potential mechanistic explanation for the neurodevelopmental defects and other related disorders reported in VPS4A-mutated patients with a fully functional VPS4B paralog.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
Alzheimer's disease (AD) exhibits mitochondrial dysfunctions associated with dysregulated metabolism, brain inflammation, synaptic loss, and neuronal cell death. As a key protein serving as the ...mitochondrial gatekeeper, the voltage-dependent anion channel-1 (VDAC1) that controls metabolism and Ca
homeostasis is positioned at a convergence point for various cell survival and death signals. Here, we targeted VDAC1 with VBIT-4, a newly developed inhibitor of VDAC1 that prevents its pro-apoptotic activity, and mitochondria dysfunction.
To address the multiple pathways involved in AD, neuronal cultures and a 5 × FAD mouse model of AD were treated with VBIT-4. We addressed multiple topics related to the disease and its molecular mechanisms using immunoblotting, immunofluorescence, q-RT-PCR, 3-D structural analysis and several behavioral tests.
In neuronal cultures, amyloid-beta (Aβ)-induced VDAC1 and p53 overexpression and apoptotic cell death were prevented by VBIT-4. Using an AD-like 5 × FAD mouse model, we showed that VDAC1 was overexpressed in neurons surrounding Aβ plaques, but not in astrocytes and microglia, and this was associated with neuronal cell death. VBIT-4 prevented the associated pathophysiological changes including neuronal cell death, neuroinflammation, and neuro-metabolic dysfunctions. VBIT-4 also switched astrocytes and microglia from being pro-inflammatory/neurotoxic to neuroprotective phenotype. Moreover, VBIT-4 prevented cognitive decline in the 5 × FAD mice as evaluated using several behavioral assessments of cognitive function. Interestingly, VBIT-4 protected against AD pathology, with no significant change in phosphorylated Tau and only a slight decrease in Aβ-plaque load.
The study suggests that mitochondrial dysfunction with its gatekeeper VDAC1 is a promising target for AD therapeutic intervention, and VBIT-4 is a promising drug candidate for AD treatment.
The delivery of therapeutic proteins to selected sites within the central nervous system (CNS) parenchyma is a major challenge in the treatment of various neurodegenerative disorders. As ...brain-derived neurotrophic factor (BDNF) is reduced in the brain of people with Alzheimer's disease (AD) and its administration has shown promising therapeutic effects in mouse model of the disease, we generated a novel platform for T cell-based BDNF delivery into the brain parenchyma.
We generated amyloid beta-protein (Aβ)-specific CD4 T cells (Aβ-T cells), genetically engineered to express BDNF, and injected them intracerebroventricularly into the 5XFAD mouse model of AD.
The BDNF-secreting Aβ-T cells migrated efficiently to amyloid plaques, where they significantly increased the levels of BDNF, its receptor TrkB, and various synaptic proteins known to be reduced in AD. Furthermore, the injected mice demonstrated reduced levels of beta-secretase 1 (BACE1)—a protease essential in the cleavage process of the amyloid precursor protein—and ameliorated amyloid pathology and inflammation within the brain parenchyma.
A T cell-based delivery of proteins into the brain can serve as a platform to modulate neurotoxic inflammation and to promote neuronal repair in neurodegenerative diseases.
Background: The delivery of therapeutic proteins to selected sites within the central nervous system (CNS) parenchyma is a major challenge in the treatment of various neurodegenerative disorders. As ...brain-derived neurotrophic factor (BDNF) is reduced in the brain of people with Alzheimer's disease (AD) and its administration has shown promising therapeutic effects in mouse model of the disease, we generated a novel platform for T cell-based BDNF delivery into the brain parenchyma. Methods: We generated amyloid beta-protein (Aβ)-specific CD4 T cells (Aβ-T cells), genetically engineered to express BDNF, and injected them intracerebroventricularly into the 5XFAD mouse model of AD. Findings: The BDNF-secreting Aβ-T cells migrated efficiently to amyloid plaques, where they significantly increased the levels of BDNF, its receptor TrkB, and various synaptic proteins known to be reduced in AD. Furthermore, the injected mice demonstrated reduced levels of beta-secretase 1 (BACE1)—a protease essential in the cleavage process of the amyloid precursor protein—and ameliorated amyloid pathology and inflammation within the brain parenchyma. Interpretation: A T cell-based delivery of proteins into the brain can serve as a platform to modulate neurotoxic inflammation and to promote neuronal repair in neurodegenerative diseases. Keywords: Cell-based delivery, CD4 T cell, BDNF, CNS, Brain, Alzheimer's disease, Amyloid plaques, Targeted drug delivery
The Kamchatka volcanic arc (Russia) is one of best-studied, but most complex tectonic margins on Earth, with an extensive geologic history extending back to the Late Cretaceous. Unlike many other ...subduction zones, primitive basalts with Mg# > 65 are abundant in Kamchatka, thereby allowing characterization of the mantle source through compositional analyses of near-liquidus minerals in the rocks. In this paper, we present a comprehensive dataset on the composition of Cr-spinel inclusions in olivine for all main Late Quaternary volcanic zones in Kamchatka, comprising 1604 analyses of spinel inclusions and their host-olivine in 104 samples from 30 volcanic complexes (single volcanoes and volcanic fields). The studied rocks are basalts, basaltic andesites and high-Mg andesites, which cover the whole compositional range of the primitive Late Quaternary volcanic rocks in Kamchatka. The spinel composition shows large variability. Spinel inclusions with the lowest Cr# and Fe3+/Fe2+ ratios were found in basalts from Sredinny Range and Northern Kamchatka, whereas the most Cr-rich and oxidized spinel inclusions occur in basalts and high-Mg andesites from the Central Kamchatka Depression. Intermediate Cr-spinel compositions characterize the Eastern Volcanic Belt of Kamchatka. The compositions of olivine-spinel pairs were used to quantify the oxidation state of parental Kamchatka magmas and the degree of partial mantle melting. The redox conditions recorded in spinel compositions range from ΔQFM = +0.7 to +3.7. ΔQFM for spinel from the Sredinny Range and Northern Kamchatka correlates with a number of whole-rock proxies for the involvement of slab-derived components (e.g., La/Nb and Ba/La), which suggests a coupling between mantle oxidation state and slab-derived fluid/melt metasomatism. These correlations were not observed in frontal Kamchatka volcanoes with the highest estimated ΔQFM, which possibly indicates buffering of the mantle oxidation state by sulfur. The estimated degrees of partial mantle melting range from 8 to >20% for Kamchatka volcanoes. Spinel from the Central Kamchatka Depression has the highest Cr# and could crystallize from magmas generated from the most depleted sources. In contrast to the Eastern Volcanic Belt, spinel Cr# and the inferred degrees of melting in the Central Kamchatka Depression do not correlate with spinel TiO2 content. The apparent decoupling between the proxies of mantle depletion in the CKD spinel is interpreted to reflect refertilization of the CKD mantle by oxidized Ti-rich slab- or mantle lithosphere-derived melts near the northern edge of the subducting Pacific Plate. This study demonstrates that the composition of Cr-spinel in volcanic rocks in combination with bulk-rock compositions can be a powerful tool to map regional variations of the mantle source depletion, oxidation state, and involvement of various slab-derived components in island-arc magmatism.
•First comprehensive dataset of spinel inclusions in high-Mg olivine from Kamchatka•Oxidation state of parental magmas of Kamchatka ranging from ΔQFM+0.7 to +3.7•ΔQFM correlates with Ba/La and La/Nb for back-arc magmas of Kamchatka•Decoupling of Cr# and TiO2 in primitive Cr-Spinel suggests slab melt contribution
PDF
